Related Experiment Video
Updated: Feb 6, 2026

Evaluation of Right Ventricular Function in Experimental Models of Pulmonary Arterial Hypertension
Published on: June 27, 2025
A multicenter study to evaluate pulmonary function in osteogenesis imperfecta.
Allison Tam1, Shan Chen1, Evan Schauer1
1Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas.
Osteogenesis imperfecta (OI) patients, especially type III, show significantly reduced lung function (FVC, FEV1). Standard "percent predicted" values mask the true extent of pulmonary issues in OI patients.
Area of Science:
- Pulmonary Medicine
- Genetics
- Orthopedics
Background:
- Pulmonary complications are a major cause of illness and death in osteogenesis imperfecta (OI).
- Systematic evaluation of pulmonary function in OI patients is limited.
- Osteogenesis imperfecta is a group of genetic disorders characterized by fragile bones.
Purpose of the Study:
- To systematically evaluate pulmonary function in a large cohort of individuals with OI.
- To assess the accuracy of standard pulmonary function metrics in OI.
- To identify correlations between lung function and clinical variables in OI.
Main Methods:
- Analysis of spirometry measurements (FVC, FEV1) in 217 individuals with OI.
- Comparison of OI pulmonary function to normal population trends.
- Use of linear mixed models to correlate lung function with clinical factors (mobility, bisphosphonate use, scoliosis).
Main Results:
- Individuals with severe OI (type III) exhibit significantly reduced FVC and FEV1.
- Standard "percent predicted" values underestimate pulmonary impairment in OI.
- Correlations found between FEV1/FVC and mobility, bisphosphonate use, and scoliosis within OI subtypes.
Conclusions:
- Pulmonary function is significantly impaired in OI, particularly in severe forms.
- Current methods for assessing lung function in OI may not fully capture the disease burden.
- Findings support the development of specific pulmonary endpoints for OI patient care and research.
More Related Videos
Related Concept Videos
Pulmonary Function Tests
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Serum Studies: Renal Function Tests
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...

